Dr. Mccormack is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 Eden Ave
Cincinnati, OH 45220Phone+1 513-558-4831Fax+1 513-558-4858- Is this information wrong?
Summary
- Dr. Francis Mccormack is a pulmonologist in Cincinnati, OH and is affiliated with multiple hospitals in the area, including University of Cincinnati Medical Center, Cincinnati Veterans Affairs Medical Center, Daniel Drake Center for Post Acute Care, and Cincinnati Children's Hospital Medical Center. He received his medical degree from University of Texas Medical Branch and has been in practice 35 years. He specializes in interstitial lung diseases and pleural disease and is experienced in interstitial lung disease, lymphangioleiomyomatosis, critical care medicine, and rare lung diseases.
Education & Training
- University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1986 - 1989
- University of Michigan Health SystemChief Residency, Internal Medicine, 1985 - 1986
- University of Michigan Health SystemResidency, Internal Medicine, 1982 - 1985
- University of Texas Medical Branch School of MedicineClass of 1982
Certifications & Licensure
- OH State Medical License 1994 - 2026
- CO State Medical License 1986 - 1995
- MI State Medical License 1985 - 1992
- TX State Medical License 1983 - 1987
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Elected Member Association of American Physicians, 2016
- Elected Member Alpha Omega Alpha, 2012
- Top 10 US Clinicial Research Achievements of 2011 Clinical Research Forum, 2011
- Join now to see all
Clinical Trials
- Efficacy and Safety of Sirolimus in LAM Start of enrollment: 2006 Dec 01
- Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) Start of enrollment: 2009 Apr 01
- Letrozole for Lymphangioleiomyomatosis Start of enrollment: 2011 May 01
- Join now to see all
Publications & Presentations
PubMed
- Interleukin 31 receptor α promotes smooth muscle cell contraction and airway hyperresponsiveness in asthma.Santhoshi V Akkenepally, Dan J K Yombo, Sanjana Yerubandi, Geereddy Bhanuprakash Reddy, Deepak A Deshpande, Francis X McCormack, Satish K Madala> ;Nature Communications. 2023 Dec 11
- Lost in translation: a neglected mTOR target for lymphangioleiomyomatosis.Jilly F Evans, Francis X McCormack, Nahum Sonenberg, Vera P Krymskaya> ;European Respiratory Review. 2023 Sep 30
- 2 citationsSingle-cell multiomic analysis identifies a HOX-PBX gene network regulating the survival of lymphangioleiomyomatosis cells.Tasnim Olatoke, Andrew Wagner, Aristotelis Astrinidis, Erik Y Zhang, Minzhe Guo, Alan G Zhang, Ushodaya Mattam, Elizabeth J Kopras, Nishant Gupta, Eric P Smith, Magdal...> ;Science Advances. 2023 May 10
- Join now to see all
Journal Articles
- The Vitamin D Binding Protein Axis Modifies Disease Severity in LymphangioleiomyomatosisFrancis Mccormack, MD, The European Respiratory Journal
- efficacy and safety of sirolimus
Press Mentions
- Innovative Imaging, Surgery Treats Lymph Condition in AdultsJanuary 10th, 2017
Grant Support
- Lung and Cardiovascular Development and Disease Pathogenesis Training ProgramNational Heart, Lung and Blood Institute2015–2020
- Pathogenesis-Driven Therapeutic Development for Pulmonary Alveolar MicrolithiasisNational Heart, Lung and Blood Institute2015–2019
- Molecular Pathway-Driven Diagnostics & Therapeutics for Rare Lung DiseasesNational Heart, Lung and Blood Institute2014–2019
- KGF-Modulation of Burn Induced Lung Injury and InfectionShriner’s of North America2013–2018
- Therapeutic strategy for Lymphangioleiomyomatosis (LAM) and Tuberous SclerosisNational Heart Lung and Blood Institute2013–2016
Committees
- Member, FDA Pulmonary and Allergy Drug Advisory Committee 2013 - 2015
- Member, American Board of Internal Medicine Pulmonary Board 2013 - 2015
- Member, Department of Defense Tuberous Sclerosis Program Vision Setting Committee 2012 - 2015
Professional Memberships
- Fellow
- Member
- Fellow
Hospital Affiliations
- University of Cincinnati Medical CenterCincinnati, Ohio
- Cincinnati Veterans Affairs Medical CenterCincinnati, Ohio
- Daniel Drake Center for Post Acute CareCincinnati, Ohio
- Cincinnati Children's Hospital Medical CenterCincinnati, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: